Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Nemvaleukin alfa combination therapy for...
Conference

Nemvaleukin alfa combination therapy for gastrointestinal (GI) cancers: Preclinical evidence and clinical data from the ARTISTRY-1 trial.

Abstract

659

Authors

Vaishampayan UN; Gandhi S; Rosen SD; Spreafico A; Bruno DS; Chu QS; Chauhan A; Dumas O; Hirte HW; Lopes JE

Volume

40

Pagination

pp. 659-659

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

February 1, 2022

DOI

10.1200/jco.2022.40.4_suppl.659

Conference proceedings

Journal of Clinical Oncology

Issue

4_suppl

ISSN

0732-183X